Anti-FGF23 antibody treatment in X Linked hypophosphatemic rickets: lights and shadows

Prevalence of osteoporosis: discrepancy according to the skeletal areas of evaluation

Raloxifene neutralizes bone brittleness induced by anti-remodeling treatment and increases fatigue life through non-cell mediated mechanisms.

PHANTOM-LESS VOLUMETRIC VERTEBRAL DENSITY OBTAINED FROM ROUTINE ABDOMINAL CT STUDIES: CORRELATION WITH DATA OBTAINED BY DXA

Effect of yerba mate (Ilex paraguariensis) on bone in ovariectomized rats

Using agents that suppress bone remodeling to treat or prevent joint disease: quo vadis?

Effects of bariatric surgery on bone

Late onset primary hypoparathyroidism associated with autoimmune disorders

Authors Guidelines

Cumulative Index